Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-11-29Clinical Trial Update: Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation [Phase 4]
A Phase 4 clinical trial comparing triple versus dual antiplatelet therapy in patients undergoing coronary stent implantation for acute coro…
-
CLINICAL_TRIALS other · 2006-11-29Clinical Trial Update: Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina [Phase 3]
Phase 3 trial of Veliflapon (DG-031) to prevent heart attacks or strokes in patients with a history of acute coronary events has been suspen…
-
FDA approval · 2006-10-04FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)
The FDA approved Civica, Inc.'s supplemental application for Heparin Sodium. This action updates the product labeling as part of the NDA 017…
-
FDA approval · 2006-08-17FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.